Vimarsana
Biggest News Aggregation in the World

Page 13 - Cingulate Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cingulate Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cingulate Inc Today - Breaking & Trending Today

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - AbCellera Biologics (NASDAQ:ABCL), Adial Pharmaceuticals (NASDAQ:ADIL) - Vimarsana News

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - AbCellera Biologics (NASDAQ:ABCL), Adial Pharmaceuticals (NASDAQ:ADIL)

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket - Vimarsana News

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gainers Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. Healthcare T...

Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD - Vimarsana News

Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD

Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its...

Why Are Cingulate Shares Trading Higher Today? - Cingulate (NASDAQ:CING) - Vimarsana News

Why Are Cingulate Shares Trading Higher Today? - Cingulate (NASDAQ:CING)

Cingulate Inc (NASDAQ: CING) announced topline results from its Phase 3 adult trial of its lead candidate, CTx-1301 (dexmethylphenidate) for attention-deficit/

Cingulate (NASDAQ:CING) Trading Down 14.4% - Vimarsana News

Cingulate (NASDAQ:CING) Trading Down 14.4%

Cingulate Inc. (NASDAQ:CING – Get Rating)’s share price traded down 14.4% during trading on Friday . The company traded as low as $0.84 and last traded at $0.84. 86,372 shares were traded during mid-day trading, a decline of 83% from the average session volume of 499,644 shares. The stock had previously closed at $0.98. Cingulate […]